Expert Theaters Supported by Grifols (non-CME)

Myth or Reality: The Rabies Threat in the US and the Role of Post-exposure Prophylaxis

Date: Saturday, April 1
Time: 1:00 – 1:45 pm

Presenter: Charles Rupprecht, VMD, PhD, Affiliate Faculty, Auburn University, Auburn, AL

This educational program will cover the prevalence of rabies in the US, pathogenesis, diagnosis, and most up-to-date treatment guidelines and best practices.

Myth or Reality: The Unknown Threat of Tetanus

Date: Sunday, April 2
Time: 1:00 – 1:45 pm

Presenter: Kumar Alagappan, MD, FACEP, Professor and Chair, Emergency Medicine, MD Anderson, University of Texas

This educational program will cover the prevalence of tetanus in the US, pathogenesis, diagnosis, and most up-to-date treatment guidelines and best practices.

Supported by

Grifols.png

Grifols is a leading global healthcare company that develops plasma-derived medicines and other innovative biopharmaceutical solutions that enable millions of patients around the world to lead more productive lives. Since our founding in 1909, we have applied our ever-growing mastery of plasma, life sciences ethical leadership and industry-leading quality and safety standards to contribute to a healthier and more sustainable society.

[ Feedback → ]